The Thalion Initiative is focused on improving the fundamental understanding of aging biology to enhance drug development and therapeutic interventions. By integrating diverse scientific disciplines, we aim to advance research methodologies and develop practical applications for aging-related conditions which account for over 70% of diseases contributing to all-cause mortality.
